| Mr Andrew Wade Simmons, ACNPC-AG | |
|
801 W Gordon St, Thomaston, GA 30286-3426 | |
| (706) 647-8111 | |
| Not Available |
| Full Name | Mr Andrew Wade Simmons |
|---|---|
| Gender | Male |
| Speciality | Clinical Nurse Specialist - Acute Care |
| Location | 801 W Gordon St, Thomaston, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033847793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2100X | Clinical Nurse Specialist - Acute Care | RN278636 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Andrew Wade Simmons, ACNPC-AG 448 Bent St, Thomaston, GA 30286-2501 Ph: (706) 975-0255 | Mr Andrew Wade Simmons, ACNPC-AG 801 W Gordon St, Thomaston, GA 30286-3426 Ph: (706) 647-8111 |
News Archive
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1.
With the recent launch of the Neurosurgical Spine Program at Saint Louis University Hospital's Center for Cerebrovascular and Skull Base Surgery, the hospital has seen a dramatic increase in the number of minimally-invasive spinal procedures, including lumbar spinal fusion surgery. Designed to stop the motion at a painful vertebral segment, this procedure is traditionally performed via a large incision on the back, stripping vital muscles away from the spine. However, the emergence of minimally-invasive neurosurgical techniques is revolutionizing spinal surgery.
The growth of emerging markets is poised to transform the delivery of surgical care around the world by 2030, according to a new report. The emphasis will be on affordable technology for early diagnosis; portable modular equipment for minimally invasive and robotic surgery; and smart systems incorporating low-cost sensors and mobile technology to track clinical outcomes and improve team-based surgery.
"In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease," said Stacy Pagos Haller, President and CEO of the American Health Assistance Foundation (AHAF), a nonprofit that identifies and funds exceptionally high-impact research worldwide through its Alzheimer's Disease Research program.
› Verified 3 days ago